Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Gastric Cancer

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    January 2012
  1. KIM GM , Jeung HC, Rha SY, Kim HS, et al
    A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.
    Eur J Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  2. WANG J , Zhang J, Wu J, Luo D, et al
    MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  3. KANG MJ , Ryoo BY, Ryu MH, Koo DH, et al
    Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experience.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  4. CERVANTES A
    Growth factor receptor-related therapy for gastric cancer.
    Eur J Cancer. 2011;47 Suppl 3:S324-5.
    PubMed     Text format     Related articles   



    July 2011
  5. THUSS-PATIENCE PC , Kretzschmar A, Bichev D, Deist T, et al
    Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer - A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. LAGERGREN J , Jansson C, Lu Y
    Motor vehicle exposure and risk of oesophageal adenocarcinoma.
    Eur J Cancer. 2011;47:1446-9.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  7. SUN T , Wang C, Xing J, Wu D, et al
    miR-429 Modulates the expression of c-myc in human gastric carcinoma cells.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  8. MOEHLER M , Mueller A, Hartmann JT, Ebert MP, et al
    An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  9. HAWKES E , Okines AF, Papamichael D, Rao S, et al
    Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.
    Eur J Cancer. 2011;47:1146-51.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  10. LJUNG R , Martin L, Lagergren J
    Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  11. MUTZE K , Langer R, Schumacher F, Becker K, et al
    DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  12. DEN HOED CM , van Eijck BC, Capelle LG, van Dekken H, et al
    The prevalence of premalignant gastric lesions in asymptomatic patients: Predicting the future incidence of gastric cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  13. LJUNG R , Martin L, Lagergren J
    Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  14. LIU R , Zhang C, Hu Z, Li G, et al
    A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  15. CORSO G , Pedrazzani C, Pinheiro H, Fernandes E, et al
    E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  16. CORSO G , Velho S, Paredes J, Pedrazzani C, et al
    Oncogenic mutations in gastric cancer with microsatellite instability.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  17. FREEDMAN ND , Derakhshan MH, Abnet CC, Schatzkin A, et al
    Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women.
    Eur J Cancer. 2010;46:2473-8.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  18. KONINGS IR , van der Gaast A, van der Wijk LJ, de Jongh FE, et al
    The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  19. WANG HJ , Ruan HJ, He XJ, Ma YY, et al
    MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
    Eur J Cancer. 2010;46:2295-303.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  20. OKINES AF , Cunningham D
    Trastuzumab in gastric cancer.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  21. WANG HJ , Ruan HJ, He XJ, Ma YY, et al
    MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  22. DASSEN AE , Lemmens VE, van de Poll-Franse LV, Creemers GJ, et al
    Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands.
    Eur J Cancer. 2010;46:1101-10.
    PubMed     Text format     Related articles    Abstract available



  23. RUTEGARD M , Shore R, Lu Y, Lagergren P, et al
    Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970-2006.
    Eur J Cancer. 2010;46:1093-100.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  24. FERLAY J , Parkin DM, Steliarova-Foucher E
    Estimates of cancer incidence and mortality in Europe in 2008.
    Eur J Cancer. 2010;46:765-81.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  25. LAI KW , Koh KX, Loh M, Tada K, et al
    MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  26. BOUVIER AM , Sant M, Verdecchia A, Forman D, et al
    What reasons lie behind long-term survival differences for gastric cancer within Europe?
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  27. NODA S , Yashiro M, Nshii T, Hirakawa K, et al
    Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  28. YUN J , Lee J, Park SH, Park JO, et al
    A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    May 2009
  29. CASSIDY A , Balsan J, Vesin A, Wu X, et al
    Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case-control study in Europe.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: